Monosomal karyotype in myeloid neoplasias: a literature review

References

• BreemsDAVan PuttenWLDe GreefGEMonosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotypeJ Clin Oncol200826294791479718695255
   PubMed Web of Science ®Google Scholar
• CampoESwerdlowSHCCHarrisLWHO classification of tumours of the haematopoietic and lymphoid tissuesLyonInternational Agency for Research on Cancer (IARC)2008
   Google Scholar
• ArberDAOraziAHasserjianRThe 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood2016127202391240527069254
   PubMed Web of Science ®Google Scholar
• SmithMLHillsRKGrimwadeDIndependent prognostic variables in acute myeloid leukaemiaBlood Rev2011251395121078537
   PubMed Web of Science ®Google Scholar
• GrimwadeDWalkerHOliverFThe importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children’s Leukaemia Working PartiesBlood1998927232223339746770
   PubMed Web of Science ®Google Scholar
• DohnerHEsteyEHAmadoriSDiagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leukemia NetBlood2010115345347419880497
   PubMed Web of Science ®Google Scholar
• GrimwadeDHillsRKMoormanAVRefinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsBlood2010116335436520385793
   PubMed Web of Science ®Google Scholar
• SlovakMLKopeckyKJCassilethPAKaryotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group StudyBlood200096134075408311110676
   PubMed Web of Science ®Google Scholar
• MedeirosBCOthusMFangMRoulstonDAppelbaumFRPrognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experienceBlood2010116132224224820562328
   PubMed Web of Science ®Google Scholar
• LowenbergBPabstTVellengaECytarabine dose for acute myeloid leukemiaN Engl J Med2011364111027103621410371
   PubMed Web of Science ®Google Scholar
• LöwenbergBOssenkoppeleGJVan PuttenWHigh-dose daunorubicin in older patients with acute myeloid leukemiaN Engl J Med2009361131235124819776405
   PubMed Web of Science ®Google Scholar
• KayserSZucknickMDohnerKMonosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesBlood2012119255155822096250
   PubMed Web of Science ®Google Scholar
• VoutiadouGPapaioannouGGaitatziMMonosomal karyotype in acute myeloid leukemia defines a distinct subgroup within the adverse cytogenetic risk categoryCancer Genet20132061–2323623246518
   PubMed Web of Science ®Google Scholar
• RuckerFGSchlenkRFBullingerLTP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeBlood201211992114212122186996
   PubMed Web of Science ®Google Scholar
• RauschTJonesDTZapatkaMGenome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutationsCell20121481–2597122265402
   PubMed Web of Science ®Google Scholar
• BochtlerTGranzowMStölzelFMarker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemiaBlood2017129101333134228119329
   PubMed Web of Science ®Google Scholar
• PerrotALuquetIPigneuxADismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalitiesBlood2011118367968521622650
   PubMed Web of Science ®Google Scholar
• HaferlachCAlpermanTSchnittgerSPrognostic value of “monosomal karyotype” in comparison to “complex aberrant karyotype” in acute myeloid leukemia: study on 824 cases with aberrant karyotypeBlood201211992122212522207733
   PubMedGoogle Scholar
• YangXFSunANYinJMonosomal karyotype among 1147 chinese patients with acute myeloid leukemia: prevalence, features and prognostic impactAsian Pac J Cancer Prev201213115421542623317194
   PubMedGoogle Scholar
• AhnHKJangJHKimKMonosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activityAm J Hematol2012871374122120708
   PubMedGoogle Scholar
• WeinbergOKOhgamiRSAcute myeloid leukemia with monosomal karyotypeAm J Clin Pathol2014142219019525015859
   PubMedGoogle Scholar
• ManolaKNPanitsasFPolychronopoulouSCytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcomeCancer Genet20132063637223411131
   PubMedGoogle Scholar
• LuQSXuNZhouXPrognostic significance of monosomal karyotype in adult patients with acute myeloid leukemia treated with risk-adapted protocolsClin Lymphoma Myeloma Leuk2015151279079626482108
   PubMedGoogle Scholar
• LazarevicVHorstedtASJohanssonBIncidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experienceBlood Cancer J20144e18824583534
   PubMed Web of Science ®Google Scholar
• FernandezHFSunZYaoXAnthracycline dose intensification in acute myeloid leukemiaN Engl J Med2009361131249125919776406
   PubMed Web of Science ®Google Scholar
• LowenbergBPabstTVellengaECytarabine dose for acute myeloid leukemiaN Engl J Med2011364111027103621410371
   PubMed Web of Science ®Google Scholar
• MedeirosBCOthusMAppelbaumFRCytarabine dose for acute myeloid leukemiaN Engl J Med20113642221672168
   PubMedGoogle Scholar
• FangMStorerBEsteyEOutcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantationBlood201111861490149421680797
   PubMedGoogle Scholar
• OranBDolanMCanQMonosomal karyotype provides better prognostic prediction after allogenic stem cell transplantation in patients with acute myelogenousBiol Blood Marrow Transplant201117335636420553926
   PubMedGoogle Scholar
• YanadaMKurosawaSYamaguchiTPrognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogenic hematopoietic cell transplantation after achieving complete remissionHaematologica201297691591822180431
   PubMed Web of Science ®Google Scholar
• CornelissenJJBreemsDLowenbergBComparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categoriesJ Clin Oncol201230172140214622564995
   PubMed Web of Science ®Google Scholar
• MoonJHLeeYJSeoSKOutcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with monosomal karyotypesActa Haematol2015133432733525503503
   PubMedGoogle Scholar
• TefferiAVardimanJWMyelodysplastic syndromesN Engl J Med2009361191872188519890130
   PubMed Web of Science ®Google Scholar
• GreenbergPCoxCLeBeauMMInternational scoring system for evaluating prognosis in myelodysplastic syndromesBlood1997896207920889058730
   PubMed Web of Science ®Google Scholar
• GreenbergPLTuechlerHSchanzJRevised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromesBlood2012120122454246522740453
   PubMed Web of Science ®Google Scholar
• SchanzJTuchlerHSoleFNew comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJ Clin Oncol201230882082922331955
   PubMed Web of Science ®Google Scholar
• HaaseDGermingUSchanzJNew insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsBlood2007110134385439517726160
   PubMed Web of Science ®Google Scholar
• PatnaikMMHansonCAHodnefieldJMMonosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotypeLeukemia201125226627021072042
   PubMed Web of Science ®Google Scholar
• ValcarcelDAdemaVSoleFComplex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndromeJ Clin Oncol201331791692223319689
   PubMed Web of Science ®Google Scholar
• SchanzJTuchlerHSoleFMonosomal karyotype in MDS: explaining the poor prognosis?Leukemia201327101988199523787396
   PubMed Web of Science ®Google Scholar
• BelliCBBengioRArangurenPNPartial and total monosomal karyotypes in myelodysplastic syndromes: comparative prognostic relevance among 421 patientsAm J Hematol201186754054521674572
   PubMedGoogle Scholar
• GangatNPatnaikMMBegnaKEvaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromesAm J Hematol201388869069323686868
   PubMed Web of Science ®Google Scholar
• CluzeauTMounierNKarsentiJMMonosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with AzacitidineAm J Hematol201388978078323757315
   PubMedGoogle Scholar
• FenauxPMuftiGJHellstrom-LindbergEEfficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyLancet Oncol200910322323219230772
   PubMed Web of Science ®Google Scholar
• LamarqueMRaynaudSItzyksonRThe revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experienceBlood2012120255084508523243156
   PubMed Web of Science ®Google Scholar
• ItzyksonRThepotSEclacheVPrognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidineLeukemia20112571207120921468040
   PubMedGoogle Scholar
• ChangCStorerBEScottBLHematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersBlood200711041379138717488876
   PubMedGoogle Scholar
• AppelbaumFRAndersonJAllogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS scoreLeukemia199812Suppl 1S25S299777891
   PubMed Web of Science ®Google Scholar
• van GelderMde WreedeLCScheteligJMonosomal karyo-type predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemiaLeukemia201327487988823164802
   PubMed Web of Science ®Google Scholar
• UstunCTrottierBJSachsZMonosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndromeBiol Blood Marrow Transplant201521586687225620751
   PubMedGoogle Scholar
• PasquiniMCZhangMJMedeirosBCHematopoietic cell transplantation outcomes in monosomal karyotype myeloid malignanciesBiol Blood Marrow Transplant201622224825726327629
   PubMed Web of Science ®Google Scholar
• KoichiroMShigematsuANakataMMonosomal karyotype in myeloid malignancies is prognostically worse even after allogeneic hematopoietic stem cell transplantation; results from two transplant centersBlood201111821 Abstract 4154
   Google Scholar
• Brands-NijenhuisAVan GelderMDe WitteTComplex karyotype predicts outcome better than monosomal karyotype in patients with MDS/secondary acute leukemia treated with allogeneic hematopoietic stem cell transplantation (HSCT): a retrospective survey on behalf of the chronic leukemia working party of the european group for blood and marrow transplantation (EBMT)Blood201011621 Abstract 578
   Google Scholar
• Della PortaMGAlessandrinoEPBacigalupoAPredicative factors for the outcome of allogenic transplantation in patients with myelodysplastic syndrome stratified according to the revised IPSS-RBlood2014123152333234224558201
   PubMed Web of Science ®Google Scholar
• CervantesFDupriezBPereiraANew prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentBlood2009113132895290118988864
   PubMed Web of Science ®Google Scholar
• PassamontiFCervantesFVannucchiAMA dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)Blood201011591703170820008785
   PubMed Web of Science ®Google Scholar
• GangatNCaramazzaDVaidyaRDIPSS-Plus: a refined dynamic international prognostic scoring system (DIPSS) for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count and transfusion statusJ Clin Oncol201129439239721149668
   PubMed Web of Science ®Google Scholar
• VaidyaRCaramazzaDBegnaKHMonosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survivalBlood2011117215612561521450904
   PubMed Web of Science ®Google Scholar
• CaramazzaDBegnaKHGangatNRefined cytogenetic risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patientsLeukemia2011251828820944670
   PubMed Web of Science ®Google Scholar
• LiBXuJLiCCytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosisAm J Hematol201489111043104625132428
   PubMedGoogle Scholar